CYP 1.72% 29.5¢ cynata therapeutics limited

Ann: Strategic Review of Cynata Clinical Development Portfolio, page-15

  1. 6,905 Posts.
    lightbulb Created with Sketch. 1280
    The preparation for the commencement of this P2 for GVHD with the FDA seems rigorous and exhausting!!

    I can’t wait!




    The can just got kicked down the road. Again.

    Confirmation that they have more than enough funds to complete the P2 GVHD trial with the FDA. Totally outsourced (as per previous announcements) by the new leader.

    Ok then.

    I can’t wait. Still!
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.005(1.72%)
Mkt cap ! $52.99M
Open High Low Value Volume
28.0¢ 29.5¢ 27.5¢ $29.94K 106.4K

Buyers (Bids)

No. Vol. Price($)
1 1000 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 10159 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.